Treated and Untreated Women with Idiopathic Precocious Puberty: Long-term Follow-up and Reproductive Outcome Between the Third and Fifth Decades
Overview
Affiliations
Context: Central precocious puberty (CPP), treated or untreated, may have implications in adulthood.
Objective: To assess the reproductive outcome and social adjustment of former CPP women between the 3rd and 5th decades of life.
Design: Cross-sectional study of an historical cohort.
Methods: Demographic data and gynaecological history of 214 CPP women aged 25-56 years [135 GnRH analogue (GnRHa)-treated, 18 cyproterone acetate (CyA)-treated, 61 untreated] and of 446 controls with normal puberty, matched for age and year of birth, were recorded in a structured interview.
Results: Marital status, education and number of children were similar in CPP women and controls. Clinical hyperandrogenism (acne/hirsutism with oligomenorrhoea) was more frequently reported in CPP women than in controls: GnRHa-treated 29·6% vs 17·4% (P = 0·006), CyA-treated 50% vs 20·4% (P = 0·04), untreated 34·4% vs 17·2% (P = 0·003), with no significant difference between CPP groups. Spontaneous pregnancy was similarly achieved by treated CPP and controls: GnRHa-treated 90·4% vs 93·4%, CyA-treated 86·7% vs 90·2%. Assisted fertilization rate was higher in untreated CPP than treated CPP groups (P = 0·006) and controls (P = 0·03). Untreated CPP was the only parameter associated with clinical hyperandrogenism (OR=2·04, 95% CI, 1·0-4·16, P = 0·07) and fertility problems (OR=3·40, 95% CI, 1·15-10·0, P = 0·047). Course of pregnancy was uneventful in 90·2% of CPP women and 90·9% of controls.
Conclusions: The increased rate of clinical hyperandrogenism among CPP women implies that the underlying neuroendocrine dysfunction persists into adult life. Pubertal suppression treatment may have a protective effect as fertility problems were more prevalent only among untreated CPP women. Educational achievements and marital status were unaffected by CPP.
Tinano F, Machado I, Latronico A, Gomes L J Neurosci. 2025; 45(11).
PMID: 40074331 PMC: 11905354. DOI: 10.1523/JNEUROSCI.1681-24.2024.
Soliman A, Alaaraj N, De Sanctis V, Hamed N, Alyafei F, Ahmed S Acta Biomed. 2023; 94(6):e2023222.
PMID: 38054666 PMC: 10734238. DOI: 10.23750/abm.v94i6.15316.
2022 Clinical practice guidelines for central precocious puberty of Korean children and adolescents.
Kim S, Kim J, Hong Y, Chung I, Lee E, Kang E Ann Pediatr Endocrinol Metab. 2023; 28(3):168-177.
PMID: 37798893 PMC: 10556443. DOI: 10.6065/apem.2346168.084.
Chu Z, Jiang H, Wu Q Zhongguo Dang Dai Er Ke Za Zhi. 2021; 23(11):1161-1168.
PMID: 34753549 PMC: 8580025. DOI: 10.7499/j.issn.1008-8830.2108078.
Karavani G, Chill H, Schachter-Safrai N, Lomnitz G, Gillis D, Bauman D Clin Diabetes Endocrinol. 2021; 7(1):14.
PMID: 34521474 PMC: 8442439. DOI: 10.1186/s40842-021-00129-4.